Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis in cancer and cancer immunotherapy
Lei Zhao, Xiaoxue Zhou, Feng Xie, et al.
Cancer Communications (2022) Vol. 42, Iss. 2, pp. 88-116
Open Access | Times Cited: 389

Showing 1-25 of 389 citing articles:

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 432
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 111
Ferroptosis as a potential target for cancer therapy
Zhen Chen, Weilong Wang, Siti Razila Abdul Razak, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 95
CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis
Yang Jiang, Junshuang Zhao, Rongqing Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 86
The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks
Jie Li, Yuchen Jia, Yi-xuan Ding, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 9, pp. 2756-2771
Open Access | Times Cited: 86
Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy
Ping Huang, Yao Yang, Wenyan Wang, et al.
Biomaterials (2023) Vol. 299, pp. 122157-122157
Closed Access | Times Cited: 55
SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase
Feng-li Xu, Xiaohong Wu, Chang Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy
Zhuangzhuang Zheng, Jing Su, Xueying Bao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
Kaisheng You, Qi Wang, Mohamed Syazwan Osman, et al.
BMEMat (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 21
The crosstalk of CD8+ T cells and ferroptosis in cancer
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 21
Cellular metabolism: A key player in cancer ferroptosis
Xianjie Jiang, Qiu Peng, Mingjing Peng, et al.
Cancer Communications (2024) Vol. 44, Iss. 2, pp. 185-204
Open Access | Times Cited: 19
Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine
Yanhong Su, Bing Liu, Binghan Wang, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 17
Nrf2: An all-rounder in depression
Chengchao Zuo, Huấn Cao, Yu Song, et al.
Redox Biology (2022) Vol. 58, pp. 102522-102522
Open Access | Times Cited: 62
Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
Xuan Liu, Yiqian Zhang, Xuyi Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
A Vanadium-Based Nanoplatform Synergizing Ferroptotic-like Therapy with Glucose Metabolism Intervention for Enhanced Cancer Cell Death and Antitumor Immunity
Yu Zhang, Xiyou Du, Zhijing He, et al.
ACS Nano (2023) Vol. 17, Iss. 12, pp. 11537-11556
Closed Access | Times Cited: 37
Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
Qiaolin Liu, Yuliang Zhao, Huige Zhou, et al.
Regenerative Biomaterials (2023) Vol. 10
Open Access | Times Cited: 34
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11
Zhichao Lang, Suhui Yu, Yuhang Hu, et al.
Phytomedicine (2023) Vol. 118, pp. 154950-154950
Open Access | Times Cited: 29
Manganese molybdate nanodots with dual amplification of STING activation for “cycle” treatment of metalloimmunotherapy
Huali Lei, Quguang Li, Guangqiang Li, et al.
Bioactive Materials (2023) Vol. 31, pp. 53-62
Open Access | Times Cited: 29
Photo‐Enhanced Synergistic Induction of Ferroptosis for Anti‐Cancer Immunotherapy
Yang Zhou, Chen Kang, Wing Kak Lin, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 27
Open Access | Times Cited: 28
Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis
Duo Wang, Guanhua Qiu, Xiaoqi Zhu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006516-e006516
Open Access | Times Cited: 27
Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy
Huali Lei, Quguang Li, Zifan Pei, et al.
Small (2023) Vol. 19, Iss. 45
Open Access | Times Cited: 26
Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis
Fang Zheng, Yeshu Wang, Qunfang Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 25
Targeting ABCB6 with nitidine chloride inhibits PI3K/AKT signaling pathway to promote ferroptosis in multiple myeloma
Zhao Yin, Yiwen Lv, Deng Li, et al.
Free Radical Biology and Medicine (2023) Vol. 203, pp. 86-101
Closed Access | Times Cited: 23
Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer
Xueyu Man, Tongfu Yang, Wenjuan Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7268-7279
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top